GRTS
Income statement / Annual
Last year (2023), Gritstone bio, Inc.'s total revenue was $1.33 M,
a decrease of 85.64% from the previous year.
In 2023, Gritstone bio, Inc.'s net income was -$138.49 M.
See Gritstone bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$1.33 M |
$9.27 M |
$46.72 M |
$4.04 M |
$4.37 M |
$1.19 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$7.59 M
|
$15.69 M
|
$14.40 M
|
$88.64 M
|
$82.90 M
|
$54.97 M
|
$1.97 M
|
$823.00 K
|
| Gross Profit |
-$6.26 M
|
-$6.42 M
|
$32.32 M
|
-$84.61 M
|
-$78.53 M
|
-$53.78 M
|
-$1.97 M
|
-$823.00 K
|
| Gross Profit Ratio |
-4.7
|
-0.69
|
0.69
|
-20.96
|
-17.99
|
-45.31
|
0
|
0
|
| Research and Development Expenses |
$127.18 M
|
$111.40 M
|
$97.49 M
|
$88.64 M
|
$82.90 M
|
$54.97 M
|
$35.69 M
|
$13.92 M
|
| General & Administrative Expenses |
$28.78 M
|
$28.97 M
|
$25.93 M
|
$21.41 M
|
$19.41 M
|
$11.81 M
|
$6.07 M
|
$5.06 M
|
| Selling & Marketing Expenses |
-$7.59 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$21.19 M
|
$28.97 M
|
$25.93 M
|
$21.41 M
|
$19.41 M
|
$11.81 M
|
$6.07 M
|
$5.06 M
|
| Other Expenses |
-$32.00 K
|
-$10.68 M
|
-$1.50 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$148.37 M
|
$129.70 M
|
$121.93 M
|
$110.05 M
|
$102.31 M
|
$66.77 M
|
$41.76 M
|
$18.98 M
|
| Cost And Expenses |
$155.97 M
|
$129.70 M
|
$121.93 M
|
$110.05 M
|
$102.31 M
|
$66.77 M
|
$41.76 M
|
$18.98 M
|
| Interest Income |
$5.20 M
|
$1.98 M
|
$164.00 K
|
$715.00 K
|
$3.51 M
|
$809.00 K
|
$386.00 K
|
$230.00 K
|
| Interest Expense |
$4.04 M
|
$1.24 M
|
$37.00 K
|
$12.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$7.59 M
|
$15.69 M
|
$14.40 M
|
$6.64 M
|
$4.75 M
|
$3.96 M
|
$1.97 M
|
$823.00 K
|
| EBITDA |
-$126.86 M |
-$111.89 M |
-$68.70 M |
-$98.67 M |
-$93.20 M |
-$61.62 M |
-$39.79 M |
-$18.16 M |
| EBITDA Ratio |
-95.31
|
-12.07
|
-1.47
|
-24.44
|
-21.35
|
-51.91
|
0
|
0
|
| Operating Income Ratio |
-116.18
|
-12.99
|
-1.61
|
-26.26
|
-22.44
|
-55.25
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.13 M
|
$741.00 K
|
$127.00 K
|
$703.00 K
|
$3.51 M
|
$809.00 K
|
$386.00 K
|
$230.00 K
|
| Income Before Tax |
-$138.49 M
|
-$119.69 M
|
-$75.08 M
|
-$105.31 M
|
-$94.43 M
|
-$64.78 M
|
-$41.38 M
|
-$18.75 M
|
| Income Before Tax Ratio |
-104.05
|
-12.91
|
-1.61
|
-26.09
|
-21.63
|
-54.57
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$138.49 M
|
-$113.13 M
|
-$74.96 M
|
-$104.61 M
|
-$90.93 M
|
-$64.78 M
|
-$41.38 M
|
-$18.75 M
|
| Net Income Ratio |
-104.05
|
-12.2
|
-1.6
|
-25.91
|
-20.83
|
-54.57
|
0
|
0
|
| EPS |
-1.2 |
-1.24 |
-0.95 |
-2.77 |
-2.71 |
-7.26 |
-2.06 |
-0.93 |
| EPS Diluted |
-1.2 |
-1.24 |
-0.95 |
-2.77 |
-2.71 |
-7.26 |
-2.06 |
-0.93 |
| Weighted Average Shares Out |
$115.53 M
|
$90.92 M
|
$78.89 M
|
$37.79 M
|
$33.55 M
|
$8.92 M
|
$20.09 M
|
$20.09 M
|
| Weighted Average Shares Out Diluted |
$115.53 M
|
$90.92 M
|
$78.89 M
|
$37.79 M
|
$33.55 M
|
$8.92 M
|
$20.09 M
|
$20.09 M
|
| Link |
|
|
|
|
|
|
|
|
